However, the HAE CHAPTER-3 and HAE CHAPTER-4 Studies for hereditary angioedema (HAE) are currently enrolling, and you may be able to take part. Learn more about these studies here.
The RAPIDe-3 Study is researching an investigational on-demand oral treatment that could help people who have swelling attacks due to hereditary angioedema (HAE).
Learn more about the study
We are currently enrolling individuals between 12 and 75 years of age who have been diagnosed with HAE type 1, 2, or 3. If you are interested in this study, complete the questionnaire to find out if you can participate.
Learn more about the RAPIDe-3 Study
*Indicates required field.
Step 1 of 3
By answering the following questions, you are not obligated to participate in this clinical research study. At the end of the questionnaire, you will have the opportunity to decide whether or not your answers are saved and/or submitted to a local research site to discuss the study further.
e.g., 12345
This website uses Secure Socket Layer technology and encryption methods to protect personal health information. If you’d like to know more about this, read the privacy policy.
Step 2 of 3
MM/DD/YYYY
By completing this questionnaire, you are agreeing to have your information retained for the duration of the study, as well as to having a research site contact you.
However, the HAE CHAPTER-3 and HAE CHAPTER-4 Studies for hereditary angioedema (HAE) are currently enrolling, and you may be able to take part.